Abnormal dendritic maturation of neurons under the influence of a Tilorone analogue (R 10.874).
Tilorone analogue (R 10.874) has a close affinity to the lysosomal compartment of cells and forms a non degradable carbohydrate-lipid-drug complex accumulated within digesting organelles. Resembling biochemical and structural changes are seen in hereditary mucopolysaccharidoses accompanied with abnormal dendritogenesis. On the other hand, developmental toxicity (TERRY et al. 1992), antiproliferative effects (ALGARRA et al. 1993) and interactions with DNA (GELLER et al. 1985) are generated by tilorone. Therefore it should be interesting to know whether the amphiphilic cationic compound is able to produce an abnormal dendritogenesis as in storage diseases or an impaired arborisation of dendrites and what could be the reason for the misdevelopment. We demonstrate that there was a fetal retardation in the development of dendritic network, even under influence of low dosis of the analogue R 10.874. The dendritic dismaturation was concomitant with an increased amount of fatty acids and a slightly disarranged metabolic pathway of gangliosides. The dendritic arborisation closed the gap of retarded development between intrauterine treated and untreated rats after 7 days of postnatal drug elimination. We suppose that a fetotoxic effect and not the lysosomopathy is responsible for the reduced dendritic network.
Pfau
D
D
Dept. of Neuropathology, Medical School, O. v. Guericke University Magdeburg, Germany.
Westphal
S
S
Bossanyi
P V
PV
Dietzmann
K
K
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D002454:Cell Differentiation / Q000187:drug effects; D003712:Dendrites / Q000187:drug effects*; D005260:Female; D009474:Neurons / Q000187:drug effects* / Q000473:pathology* / Q000648:ultrastructure; D051381:Rats; D017208:Rats, Wistar; D013131:Spine / Q000187:drug effects / Q000473:pathology; D013501:Surface-Active Agents / Q000494:pharmacology*; D013994:Tilorone / Q000031:analogs & derivatives* / Q000494:pharmacology*
C103509:R 10.874; D013501:Surface-Active Agents; D013994:Tilorone